Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Future of Precision Medicine in the Cure of Alzheimer’s Disease
Azher Arafah, Saima Khatoon, Iyman Rasool, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 335-335
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

A Transfer Learning Approach: Early Prediction of Alzheimer’s Disease on US Healthy Aging Dataset
C. Kishor Kumar Reddy, Aarti Rangarajan, Deepti Rangarajan, et al.
Mathematics (2024) Vol. 12, Iss. 14, pp. 2204-2204
Open Access | Times Cited: 17
Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
Daniela Dias, Renato Socodato
Biomedicines (2025) Vol. 13, Iss. 2, pp. 279-279
Open Access | Times Cited: 2
Phenotyping to predict 12-month health outcomes of older general medicine patients
Richard Woodman, Kimberly Bryant, Michael J. Sorich, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access | Times Cited: 2
Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects
Idiongo Okon Umoh, Helton José Reis, Antônio Carlos Pinheiro de Oliveira
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3044-3044
Open Access | Times Cited: 9
The role of machine learning in discovering biomarkers and predicting treatment strategies for neurodegenerative diseases: A narrative review
Abdullahi Tunde Aborode, Ogunware Adedayo Emmanuel, Isreal Ayobami Onifade, et al.
NeuroMarkers. (2025) Vol. 2, Iss. 1, pp. 100034-100034
Open Access | Times Cited: 1
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 8
MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)
Walter J. Lukiw
Biology (2023) Vol. 12, Iss. 6, pp. 788-788
Open Access | Times Cited: 16
Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer’s agents
Willian Orlando Castillo Ordoñez, Nohelia Cajas‐Salazar, Mayra Alejandra Velasco-Reyes
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 846-854
Open Access | Times Cited: 16
A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease
Gayatri Devi
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 15
A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
Kuldeep Singh, Jeetendra Kumar Gupta, Shivendra Kumar, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 7, pp. 507-526
Closed Access | Times Cited: 6
Chemistry, Biological Activities, and Pharmacological Properties of Gastrodin: Mechanism Insights
Naoual El Menyiy, Youssef Elouafy, Rania Moubachir, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 4
Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers
Joachim Strobel, Elham Yousefzadeh-Nowshahr, Katharina Deininger, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 4
Recent Insights into the Neurobiology of Alzheimer’s Disease and Advanced Treatment Strategies
Kuttiappan Anitha, Mandeep Kumar Singh, Komal Kohat, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment
César Cáceres, Bernardita Heusser, Alexandra L. Garnham, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2669-2669
Open Access | Times Cited: 10
Dietary supplementation and the role of phytochemicals against the Alzheimer's disease: Focus on polyphenolic compounds
Rayees Ahmad Naik, Roshni Rajpoot, Raj Kumar Koiri, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100004-100004
Open Access
Exploring sex differences in Alzheimer’s disease: a comprehensive analysis of a large patient cohort from a memory unit
Maitée Rosende‐Roca, Fernando García‐Gutiérrez, Yahveth Cantero‐Fortiz, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Weight trajectories in aging humanized APOE mice with translational validity to human Alzheimer’s risk population: A retrospective analysis
Francesca Vitali, Jean-Paul Wiegand, Lillian Parker-Halstead, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314097-e0314097
Open Access
Non-coding RNAs in the pathogenesis of Alzheimer’s disease: β-amyloid aggregation, Tau phosphorylation and neuroinflammation
Irma A. Jiménez‐Ramírez, Enrique Castaño
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Promising Natural Remedies for Alzheimer’s Disease Therapy
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 922-922
Open Access
Polymerase Chain Reaction Chips for Biomarker Discovery and Validation in Drug Development
Dang-Khoa Vo, Kieu The Loan Trinh
Micromachines (2025) Vol. 16, Iss. 3, pp. 243-243
Open Access
The role of fusion proteins as biomarkers and therapeutic agents for Alzheimer's disease: A narrative review
Dessy Agustini, Rohan Sabloak, Shemonti Hasan, et al.
NeuroMarkers. (2025) Vol. 2, Iss. 2, pp. 100041-100041
Open Access
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system
Jingjing Huang, Xiaohong Long, Chunyong Chen
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Exploring interdisciplinary perspectives on the implementation of personalized medicine and patient-orchestrated care in Alzheimer's disease: A qualitative study within the ABOARD research project
Tanja J. de Rijke, Dianne Vasseur, Wiesje M. van der Flier, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Infections, Genetics, and Alzheimer's Disease: Exploring the Pathogenic Factors for Innovative Therapies
Ramesh Kordi, T. John Andrews, Mark D. Hicar
Virology (2025), pp. 110523-110523
Closed Access
Page 1 - Next Page

Scroll to top